BSE Live
Dec 09, 14:20Prev. Close
860.00
Open Price
863.70
Bid Price (Qty.)
881.35 (11)
Offer Price (Qty.)
882.95 (11)
NSE Live
Dec 09, 14:20Prev. Close
860.10
Open Price
856.00
Bid Price (Qty.)
882.25 (6)
Offer Price (Qty.)
882.50 (126)
| Profit & Loss account of Sai Life Sciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
| 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | |||||
| Revenue From Operations [Gross] | 1,660.39 | 1,468.72 | 1,196.95 | 869.12 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 1,660.39 | 1,468.72 | 1,196.95 | 869.12 | |
| Total Operating Revenues | 1,694.57 | 1,465.18 | 1,217.14 | 869.59 | |
| Other Income | 36.78 | 29.09 | 27.97 | 28.15 | |
| Total Revenue | 1,731.35 | 1,494.27 | 1,245.11 | 897.74 | |
| EXPENSES | |||||
| Cost Of Materials Consumed | 460.80 | 423.30 | 427.18 | 269.59 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FGWIP And Stock In Trade | 4.97 | 22.43 | -4.59 | -2.83 | |
| Employee Benefit Expenses | 549.12 | 494.91 | 417.29 | 308.97 | |
| Finance Costs | 76.16 | 85.91 | 77.06 | 49.57 | |
| Depreciation And Amortisation Expenses | 138.57 | 119.44 | 99.43 | 90.16 | |
| Other Expenses | 274.03 | 239.05 | 212.34 | 172.58 | |
| Total Expenses | 1,503.65 | 1,385.04 | 1,228.70 | 888.05 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 227.70 | 109.23 | 16.41 | 9.70 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 227.70 | 109.23 | 16.41 | 9.70 | |
| Tax Expenses-Continued Operations | |||||
| Current Tax | 33.84 | 7.76 | 10.03 | 9.42 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 23.73 | 18.67 | -3.61 | -5.95 | |
| Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 57.57 | 26.43 | 6.42 | 3.47 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 170.13 | 82.81 | 9.99 | 6.23 | |
| Profit/Loss From Continuing Operations | 170.13 | 82.81 | 9.99 | 6.23 | |
| Profit/Loss For The Period | 170.13 | 82.81 | 9.99 | 6.23 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | |
| Consolidated Profit/Loss After MI And Associates | 170.13 | 82.81 | 9.99 | 6.23 | |
| OTHER ADDITIONAL INFORMATION | |||||
| EARNINGS PER SHARE | |||||
| Basic EPS (Rs.) | 9.00 | 5.00 | 1.00 | 0.00 | |
| Diluted EPS (Rs.) | 9.00 | 5.00 | 1.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | |||||
| Equity Share Dividend | 0.00 | 0.00 | 6.90 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 |
12.11.2025
Sai Life Sci Standalone September 2025 Net Sales at Rs 526.67 crore, up 37.88% Y-o-Y
07.11.2025
Sai Life Sci Consolidated September 2025 Net Sales at Rs 537.47 crore, up 35.88% Y-o-Y
28.08.2025
26.08.2025
12.11.2025
Sai Life Sci Standalone September 2025 Net Sales at Rs 526.67 crore, up 37.88% Y-o-Y
07.11.2025
Sai Life Sci Consolidated September 2025 Net Sales at Rs 537.47 crore, up 35.88% Y-o-Y
22.08.2025
Sai Life Sci Standalone June 2025 Net Sales at Rs 483.04 crore, up 82.64% Y-o-Y
14.05.2025
Sai Life Sci Standalone March 2025 Net Sales at Rs 567.01 crore, up 32.62% Y-o-Y